Cargando…
Suppression of NANOG Expression Reduces Drug Resistance of Cancer Stem Cells in Glioblastoma
Glioblastoma (GBM) is an aggressive and incurable primary brain tumor that harbors therapy-resistant cancer stem cells (CSCs). Due to the limited effectiveness of conventional chemotherapies and radiation treatments against CSCs, there is a critical need for the development of innovative therapeutic...
Autores principales: | Smith, Jonhoi, Field, Melvin, Sugaya, Kiminobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297980/ https://www.ncbi.nlm.nih.gov/pubmed/37372456 http://dx.doi.org/10.3390/genes14061276 |
Ejemplares similares
-
Coculture with Neural Stem Cells May Shift the Transcription Profile of Glioblastoma Multiforme towards Cancer-Specific Stemness
por: Vaidya, Manjusha, et al.
Publicado: (2023) -
Analysis of regulatory sequences in exosomal DNA of NANOGP8
por: Vaidya, Manjusha, et al.
Publicado: (2023) -
Differential sequences of exosomal NANOG DNA as a potential diagnostic cancer marker
por: Vaidya, Manjusha, et al.
Publicado: (2018) -
MiR-134 regulates the proliferation and invasion of glioblastoma cells by reducing Nanog expression
por: NIU, CHAO SHI, et al.
Publicado: (2013) -
CD24 and Nanog expression in Stem Cells in Glioblastoma: Correlation with Response to Chemoradiation and Overall Survival
por: Soni, Priyanka, et al.
Publicado: (2017)